Biologics Spine Xtant Medical Wins Auction for Surgalign’s Hardware and Biologics Business byJosh SandbergJuly 28, 2023
Financial Xtant Medical Announces Closing of $15 Million Private Placement byJosh SandbergJuly 7, 2023
Biologics Spine Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors byJosh SandbergMay 18, 2023
Financial Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue Guidance byJosh SandbergMay 4, 2023
Financial Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results byJosh SandbergMarch 7, 2023
Financial Spine Top Stories Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million byJosh SandbergMarch 1, 2023
Biologics Spine Top Stories Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer byChris StewartJanuary 9, 2023
Financial Xtant Medical Announces Third Quarter 2022 Financial Results byJosh SandbergNovember 3, 2022
